• Explore /
  • Poster
  • / Identification and management of clonal hematopoiesis of indeterminate potential (CHIP) in cancer survivors: The Cleveland Clinic experience.

Identification and management of clonal hematopoiesis of indeterminate potential (CHIP) in cancer survivors: The Cleveland Clinic experience.

Abstract Poster

Authors

null

Teodora Kuzmanovic

Cleveland Clinic, Cleveland, OH

Teodora Kuzmanovic , Donna Horvath , Maurice Slaughter , Natalya Karasik , David Bosler , Halle C. F. Moore , Jame Abraham , Jessica Lyn Geiger , Pauline Funchain , Aaron Thomas Gerds , Anjali S. Advani , Sudipto Mukherjee , John Carlos Molina , Sophia Rebecca Balderman , Mikkael A. Sekeres , Jaroslaw P. Maciejewski , Brian James Bolwell , Hetty E Carraway , Bhumika J Patel , Abhay Singh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Other Leukemia, Myelodysplastic Syndromes, and Allotransplant

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7010)

DOI

10.1200/JCO.2023.41.16_suppl.7010

Abstract #

7010

Poster Bd #

140

Abstract Disclosures

Similar Posters

First Author: Mohammad Issam Abu Zaid

Poster

2019 ASCO Annual Meeting

The CAROLE (CArdiac Related Oncologic Late Effects) Study: A Phase II, single-arm feasibility trial.

The CAROLE (CArdiac Related Oncologic Late Effects) Study: A Phase II, single-arm feasibility trial.

First Author: Lindsay Puckett

First Author: Michael Marquardt

First Author: Allen M. Chen